OWINGS MILLS, Md., Jan. 8, 2014 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, is proud to announce its ranking as the nation's third most popular diet by DietsInReview.com's "2013 Most Popular Diets of the Year." The website just announced the 25 most popular diets of 2013.
DietsInReview.com provides information and education from health professionals to support individuals as they implement healthy lifestyle and nutrition choices, manage their weight, and learn how to live a healthier life. At the end of each year, DietsInReview.com ranks the most popular US diets, and, for the past two years, Medifast has ranked third.
"It is an honor to be recognized as a leading brand in the United States by consumers and DietsInReview.com," said Michael C. MacDonald, Medifast's Chairman and Chief Executive Officer. "Medifast is designed to help people lose weight and learn the habits of a healthy lifestyle with the help of our products and multiple support options."
To learn more about Medifast, please visit www.medifastnow.com.About Medifast: Medifast (NYSE: MED) is the leading easy-to-use, clinically proven, portion-controlled weight-loss program. The company sells its products and programs via four unique distribution channels: 1) the web and national call centers, 2) the Take Shape For Life personal coaching division, 3) Medifast Weight Control Centers, and 4) a national network of physicians. Medifast was founded in 1980 and is located in Owings Mills, Maryland. For more information, log onto www.MedifastNow.com. SOURCE Medifast, Inc.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts